Ashwal Eran, Berger Howard, Hiersch Liran, Yoon Eugene W, Zaltz Arthur, Shah Baiju, Halperin Ilana, Barrett Jon, Melamed Nir
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Tel Aviv Sourasky Medical Center, Lis Maternity Hospital, Tel Aviv University, Tel Aviv, Israel.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Saint Michaels Hospital, Toronto, Ontario, Canada.
Am J Obstet Gynecol. 2021 Oct;225(4):420.e1-420.e13. doi: 10.1016/j.ajog.2021.04.225. Epub 2021 Apr 17.
Gestational diabetes mellitus is associated with accelerated fetal growth in singleton pregnancies but may affect twin pregnancies differently because of the slower growth of twin fetuses during the third trimester of pregnancy and their greater predisposition to fetal growth restriction.
This study aimed to evaluate the association of gestational diabetes mellitus with longitudinal fetal growth in twin pregnancies and to compare this association with that observed in singleton pregnancies.
This was a retrospective cohort study of all women with a singleton or twin pregnancy who were followed up at a single tertiary referral center between January 2011 and April 2020. Data on estimated fetal weight and individual fetal biometric indices were extracted from ultrasound examinations of eligible women. Generalized linear models were used to model and compare the change in fetal weight and individual biometric indices as a function of gestational age between women with and without gestational diabetes mellitus in twin pregnancies and between women with and without gestational diabetes mellitus in singleton pregnancies. The primary outcome was estimated fetal weight as a function of gestational age. The secondary outcomes were longitudinal growth of individual fetal biometric indices and the rate of small for gestational age and large for gestational age at birth.
A total of 26,651 women (94,437 ultrasound examinations) were included in the analysis: 1881 with a twin pregnancy and 24,770 with a singleton pregnancy. The rate of gestational diabetes mellitus in the twin and singleton groups was 9.6% (n=180) and 7.6% (n=1893), respectively. The estimated fetal weight in singleton pregnancies with gestational diabetes mellitus was significantly higher than that in pregnancies without gestational diabetes mellitus (P<.001) starting at approximately 30 weeks of gestation. The differences remained similar after adjusting for maternal age, chronic hypertension, nulliparity, and neonatal sex (P<.001). In twin pregnancies, fetal growth was similar between pregnancies with and without gestational diabetes mellitus (P=.105 and P=.483 for unadjusted and adjusted models, respectively). The findings were similar to the association of gestational diabetes mellitus with the risk of large for gestational fetuses and the growth of each biometric index. When stratified by type of gestational diabetes mellitus treatment, twin pregnancies with gestational diabetes mellitus was associated with accelerated fetal growth only in the subgroup of women with medically treated gestational diabetes mellitus (P<.001), which represented 12% (n=21) of the twin pregnancy group with gestational diabetes mellitus.
In contrast to singleton pregnancies, twin pregnancies with gestational diabetes mellitus is less likely to be associated with accelerated fetal growth. This finding has raised the question of whether the diagnostic criteria for gestational diabetes mellitus and the blood glucose targets in women diagnosed with gestational diabetes mellitus should be individualized for twin pregnancies.
妊娠期糖尿病与单胎妊娠中胎儿生长加速有关,但可能对双胎妊娠产生不同影响,因为双胎胎儿在妊娠晚期生长较慢,且更易发生胎儿生长受限。
本研究旨在评估妊娠期糖尿病与双胎妊娠中胎儿纵向生长的关联,并将这种关联与单胎妊娠中的情况进行比较。
这是一项回顾性队列研究,研究对象为2011年1月至2020年4月在单一三级转诊中心接受随访的所有单胎或双胎妊娠女性。从符合条件的女性超声检查中提取估计胎儿体重和个体胎儿生物测量指标的数据。使用广义线性模型对双胎妊娠中有或无妊娠期糖尿病的女性以及单胎妊娠中有或无妊娠期糖尿病的女性之间,胎儿体重和个体生物测量指标随孕周变化的情况进行建模和比较。主要结局是作为孕周函数的估计胎儿体重。次要结局是个体胎儿生物测量指标的纵向生长以及出生时小于胎龄和大于胎龄的发生率。
共有26651名女性(94437次超声检查)纳入分析:1881例双胎妊娠和24770例单胎妊娠。双胎组和单胎组的妊娠期糖尿病发生率分别为9.6%(n = 180)和7.6%(n = 1893)。妊娠糖尿病的单胎妊娠中,估计胎儿体重从妊娠约30周开始显著高于无妊娠糖尿病的妊娠(P <.001)。在调整产妇年龄、慢性高血压、初产和新生儿性别后,差异仍然相似(P <.001)。在双胎妊娠中,有和无妊娠期糖尿病的妊娠胎儿生长相似(未调整模型和调整模型的P值分别为0.105和0.483)。这些发现与妊娠期糖尿病与大于胎龄胎儿风险及各生物测量指标生长的关联相似。按妊娠期糖尿病治疗类型分层时,仅在接受药物治疗的妊娠期糖尿病女性亚组中,双胎妊娠合并妊娠期糖尿病与胎儿生长加速有关(P <.001),该亚组占双胎妊娠合并妊娠期糖尿病组的12%(n = 21)。
与单胎妊娠不同,双胎妊娠合并妊娠期糖尿病与胎儿生长加速的关联较小。这一发现引发了妊娠期糖尿病的诊断标准以及诊断为妊娠期糖尿病的女性的血糖目标是否应针对双胎妊娠个体化的问题。